Correction to: Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS‑CoV‑2 infectivity

Affiliations

• ¹ Translational Immunology Laboratory, Health Research Institute of Asturias (ISPA), Oviedo, Spain.
• ² Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain.
• ³ Intensive Care Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
• ⁴ Translational Microbiology Research Group, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
• ⁵ Infectious Diseases Unit, Translational Research in Infectious Diseases Group, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), OviedoOviedo, Spain.
• ⁶ Translational Immunology Laboratory, Health Research Institute of Asturias (ISPA), Oviedo, Spain. [email protected].
• ⁷ Department of Immunology, Hospital Universitario Central De Asturias, Oviedo, Spain. [email protected].